Quarterly report pursuant to Section 13 or 15(d)

Basis of Presentation and Significant Accounting Policies (Details Narrative)

v3.20.2
Basis of Presentation and Significant Accounting Policies (Details Narrative)
$ in Thousands
1 Months Ended 3 Months Ended 9 Months Ended
Jun. 30, 2020
USD ($)
Sep. 30, 2020
USD ($)
Sep. 30, 2019
USD ($)
Sep. 30, 2020
USD ($)
Segment
Sep. 30, 2019
USD ($)
Dec. 31, 2019
USD ($)
Number of operating segment | Segment       1    
Primary operating account balance   $ 31,781   $ 31,781   $ 7,418
Cash uninsured amount   50   50    
Goodwill   19,092   19,092   $ 19,092
Impairment in goodwill       $ 46,103  
Collaboration revenue   489 $ 492 1,504 $ 6,162  
Franchise Taxes [Member]            
Deferred tax credits $ 126          
Income tax expense $ 51          
Amortized until prepaid expense       $ 75    
Amortized until prepaid expense maturity date       Sep. 30, 2021    
Merck Sharp & Dohme Corp [Member]            
Accounts receivable related party   581   $ 581    
Merck Sharp & Dohme Corp [Member] | Customer One [Member] | Customer Concentration Risk [Member] | Revenue and Receivables [Member]            
Revenue and receivable percentage       100.00%    
U.S. Financial Institutions One [Member]            
Cash FDIC insured limits   250   $ 250    
U.S. Financial Institutions Two [Member]            
Cash FDIC insured limits   $ 250   $ 250